Cannabis use alleviates pain in diabetic subjects suffering from neuropathy that’s resistant to standard treatment, according to a new study being published in The Journal of Pain, and published online ahead of print by the U.S. National Institute of Health.
For the study, researchers examined the efficacy of inhaled cannabis (versus a placebo) in 16 patients with intense diabetic peripheral neuropathy.
“This small, short-term, placebo-controlled trial of inhaled cannabis demonstrated a dose-dependent reduction in diabetic peripheral neuropathy pain in patients with treatment-refractory pain”, claims the study’s abstract. “Overall, our finding of an analgesic effect of cannabis is consistent with other trials of cannabis in diverse neuropathic pain syndromes.”
The study, which can be found by clicking here, was conducted by researchers at the University of California, San Diego.